Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2017 (2017), Article ID 3967595, 8 pages
https://doi.org/10.1155/2017/3967595
Research Article

Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect

Department of Cardiovascular Medicine, Nephrology and Neurology, Graduate School of Medicine, University of the Ryukyus, Okinawa Prefecture, Japan

Correspondence should be addressed to Masanobu Yamazato; pj.ca.nimu@kyr-zamayam

Received 17 November 2016; Revised 20 February 2017; Accepted 27 February 2017; Published 22 March 2017

Academic Editor: Tomohiro Katsuya

Copyright © 2017 Takuto Nakamura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Kubota, Y. Numaguchi, M. Ishii et al., “Ischemia-induced angiogenesis is impaired in aminopeptidase A deficient mice via down-regulation of HIF-1α,” Biochemical and Biophysical Research Communications, vol. 402, no. 2, pp. 396–401, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Mizutani, J. Wright, and H. Kobayashi, “A new approach regarding the treatment of preeclampsia and preterm labor,” Life Sciences, vol. 88, no. 1-2, pp. 17–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. X. Wang, Q. F. Zhang, X. J. Zeng, W. Wang, C. S. Tang, and L. K. Zhang, “Effects of angiotensin III on protein, DNA, and collagen synthesis of neonatal cardiomyocytes and cardiac fibroblasts in vitro,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 15, no. 4, pp. 393–402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. S. Alghamri, M. Morris, J. G. Meszaros, K. M. Elased, and N. Grobe, “Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 306, no. 7, pp. H1032–H1040, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Zini, P. Masdehors, Z. Lenkei et al., “Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats,” Neuroscience, vol. 78, no. 4, pp. 1187–1193, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. D. P. Healy and L. Song, “Kidney aminopeptidase A and hypertension, part I: spontaneously hypertensive rats,” Hypertension, vol. 33, no. 2, pp. 740–745, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Reaux, M. C. Fournie-Zaluski, C. David et al., “Aminopeptidase A inhibitors as potential central antihypertensive agents,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 23, pp. 13415–13420, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Bodineau, A. Frugière, Y. Marc et al., “Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension,” Hypertension, vol. 51, no. 5, pp. 1318–1325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Marc, J. Gao, F. Balavoine, A. Michaud, B. P. Roques, and C. Llorens-Cortes, “Central antihypertensive effects of orally active aminopeptidase a inhibitors in spontaneously hypertensive rats,” Hypertension, vol. 60, no. 2, pp. 411–418, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M.-C. Fournie-Zaluski, C. Fassot, B. Valentin et al., “Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 20, pp. 7775–7780, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Gao, Y. Marc, X. Iturrioz, V. Leroux, F. Balavoine, and C. Llorens-Cortes, “A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors,” Clinical Science, vol. 127, no. 3, pp. 135–148, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. W. Wright, S. Mizutani, and J. W. Harding, “Focus on brain angiotensin III and aminopeptidase a in the control of hypertension,” International Journal of Hypertension, vol. 2012, Article ID 124758, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. V. G. Yugandhar and M. A. Clark, “Angiotensin III: a physiological relevant peptide of the renin angiotensin system,” Peptides, vol. 46, pp. 26–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. W. Wright, S. L. Morseth, R. H. Abhold, and J. W. Harding, “Pressor action and dipsogenicity induced by angiotensin II and III in rats,” The American Journal of Physiology, vol. 249, part 2, no. 5, part 2, pp. R514–R521, 1985. View at Google Scholar · View at Scopus
  15. F. Faber, F. Gembardt, X. Sun, S. Mizutani, W.-E. Siems, and T. Walther, “Lack of angiotensin II conversion to angiotensin III increases water but not alcohol consumption in aminopeptidase A-deficient mice,” Regulatory Peptides, vol. 136, no. 1–3, pp. 130–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Goto, A. Hattori, Y. Ishii, S. Mizutani, and M. Tsujimoto, “Enzymatic properties of human aminopeptidase A: regulation of its enzymatic activity by calcium and angiotensin IV,” The Journal of Biological Chemistry, vol. 281, no. 33, pp. 23503–23513, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. L. Alvarez, A. Delorenzi, D. Santajuliana, S. Finkielman, V. E. Nahmod, and C. J. Pirola, “Central bradykininergic system in normotensive and hypertensive rats,” Clinical Science, vol. 82, no. 5, pp. 513–519, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Cloutier, B. Ongali, M. M. Campos, G. Thibault, W. Neugebauer, and R. Couture, “Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats,” British Journal of Pharmacology, vol. 142, no. 2, pp. 285–296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. P. J. Privitera, H. Thibodeaux, and P. Yates, “Rostral ventrolateral medulla as a site for the central hypertensive action of kinins,” Hypertension, vol. 23, no. 1, pp. 52–58, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Emanueli, J. Chao, D. Regoli, L. Chao, A. Ni, and P. Madeddu, “The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats,” British Journal of Pharmacology, vol. 126, no. 8, pp. 1769–1776, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. H. De Brito Gariepy, P. Carayon, B. Ferrari, and R. Couture, “Contribution of the central dopaminergic system in the anti-hypertensive effect of kinin B1 receptor antagonists in two rat models of hypertension,” Neuropeptides, vol. 44, no. 2, pp. 191–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Naffah-Mazzacoratti Mda, T. L. Gouveia, P. S. Simões, and S. R. Perosa, “What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?” World Journal of Biological Chemistry, vol. 5, no. 2, pp. 130–140, 2014. View at Google Scholar
  23. P. J. Privitera and P. Yates, “Hypertensive effect of tissue kallikrein in rostral ventrolateral medulla is mediated by brain kinins,” Brain Research, vol. 704, no. 1, pp. 103–106, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Yamazato, C. Zukeran, H. Teruya et al., “Ouabain-like immunoreactivity in the medulla oblongata of rats,” Archives of Histology and Cytology, vol. 61, no. 4, pp. 317–326, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Yamazato, Y. Ohya, M. Nakamoto et al., “Sympathetic hyperreactivity to air-jet stress in the chromosome 1 blood pressure quantitative trait locus congenic rats,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 290, no. 3, pp. R709–R714, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. N. de Mota, X. Iturrioz, C. Claperon et al., “Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei,” Journal of Neurochemistry, vol. 106, no. 1, pp. 416–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. W. Wright, S. Mizutani, C. E. Murray, H. Z. Amir, and J. W. Harding, “Aminopeptidase-induced elevations and reductions in blood pressure in the spontaneously hypertensive rat,” Journal of Hypertension, vol. 8, no. 10, pp. 969–974, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. F. M. A. Corrêa and F. G. Graeff, “Central mechanisms of the hypertensive action of intraventricular bradykinin in the unanaesthetized rat,” Neuropharmacology, vol. 13, no. 1, pp. 65–75, 1974. View at Publisher · View at Google Scholar · View at Scopus
  29. B. S. Huang, M. Ahmad, R. A. White, Y. Marc, C. Llorens-Cortes, and F. H. H. Leenen, “Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction,” Cardiovascular Research, vol. 97, no. 3, pp. 424–431, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Balavoine, M. Azizi, D. Bergerot et al., “Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug,” Clinical Pharmacokinetics, vol. 53, no. 4, pp. 385–395, 2014. View at Publisher · View at Google Scholar · View at Scopus